Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Molecular Cancer|June 14, 2013
EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growthAgnieszka Martowicz, Johannes Rainer, Julien Lelong, et al.
Mechanisms of Ageing and Development|December 22, 2004
Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiationGerold Untergasser, Roland Gander, Claudia Lilg, et al.
Frontiers in Oncology|February 11, 2020
Spliced XBP1 Levels Determine Sensitivity of Multiple Myeloma Cells to Proteasome Inhibitor Bortezomib Independent of the Unfolded Protein Response Mediator GRP78Bojana Borjan, Johann Kern, Normann Steiner, et al.
Endocrinology|June 18, 2010
Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasiaChristoph Zenzmaier, Natalie Sampson, Dominik Pernkopf, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2002
Trans-differentiation of prostatic stromal cells leads to decreased glycoprotein hormone alpha productionHolger Rumpold, Katarina Mascher, Gerold Untergasser, et al.
The Prostate|February 6, 2008
Dysregulation of Dkk-3 expression in benign and malignant prostatic tissueChristoph Zenzmaier, Gerold Untergasser, Martin Hermann, et al.
The Prostate|September 21, 2002
Neuroendocrine differentiation of human prostatic primary epithelial cells in vitroHolger Rumpold, Elmar Heinrich, Gerold Untergasser, et al.
Stem Cells (Dayton, Ohio)|June 13, 2009
Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in miceTrevor Lucas, Dietmar Abraham, Gerold Untergasser, et al.
Blood|August 29, 2009
GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomibJohann Kern, Gerold Untergasser, Christoph Zenzmaier, et al.
Anticancer Research|September 9, 2018
The Plasma Levels of the Angiogenic Cytokine Endocan Are Elevated in Patients with Multiple MyelomaNormann Steiner, Roman Hajek, Sabina Sevcikova, et al.
Pageof 6